- Home
- FLGT vs BOE Comparison
FLGT vs BOE Comparison
Compare FLGT & BOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- BOE
- Stock Information
- Founded
- FLGT 2011
- BOE 2005
- Country
- FLGT United States
- BOE United States
- Employees
- FLGT N/A
- BOE N/A
- Industry
- FLGT Medical Specialities
- BOE Trusts Except Educational Religious and Charitable
- Sector
- FLGT Health Care
- BOE Finance
- Exchange
- FLGT Nasdaq
- BOE Nasdaq
- Market Cap
- FLGT 697.3M
- BOE 638.8M
- IPO Year
- FLGT 2016
- BOE N/A
- Fundamental
- Price
- FLGT $23.00
- BOE $11.75
- Analyst Decision
- FLGT Buy
- BOE
- Analyst Count
- FLGT 3
- BOE 0
- Target Price
- FLGT $25.33
- BOE N/A
- AVG Volume (30 Days)
- FLGT 228.6K
- BOE 166.1K
- Earning Date
- FLGT 11-07-2025
- BOE 01-01-0001
- Dividend Yield
- FLGT N/A
- BOE 7.30%
- EPS Growth
- FLGT N/A
- BOE N/A
- EPS
- FLGT N/A
- BOE N/A
- Revenue
- FLGT $303,223,000.00
- BOE N/A
- Revenue This Year
- FLGT $15.19
- BOE N/A
- Revenue Next Year
- FLGT $10.58
- BOE N/A
- P/E Ratio
- FLGT N/A
- BOE N/A
- Revenue Growth
- FLGT 4.31
- BOE N/A
- 52 Week Low
- FLGT $14.57
- BOE $8.80
- 52 Week High
- FLGT $23.57
- BOE $10.48
- Technical
- Relative Strength Index (RSI)
- FLGT 60.31
- BOE 65.51
- Support Level
- FLGT $22.05
- BOE $11.41
- Resistance Level
- FLGT $23.57
- BOE $11.78
- Average True Range (ATR)
- FLGT 0.68
- BOE 0.09
- MACD
- FLGT 0.02
- BOE 0.01
- Stochastic Oscillator
- FLGT 74.94
- BOE 89.19
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.